Related Experiment Video
Updated: Mar 9, 2026

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
Published on: February 22, 2020
Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival
Charlotte Viant1, Sophie Guia1, Robert J Hennessy2,3
1Centre d'Immunologie de Marseille-Luminy (CIML), Aix-Marseille Université, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), 13288 Marseille, France.
Abstract:
Natural killer (NK) cells are innate lymphoid cells with antitumor functions. Using an N-ethyl-N-nitrosourea (ENU)-induced mutagenesis screen in mice, we identified a strain with an NK cell deficiency caused by a hypomorphic mutation in the Bcl2 (B cell lymphoma 2) gene. Analysis of these mice and the conditional deletion of Bcl2 in NK cells revealed a nonredundant intrinsic requirement for BCL2 in NK cell survival. In these mice, NK cells in cycle were protected against apoptosis, and NK cell counts were restored in inflammatory conditions, suggesting a redundant role for BCL2 in proliferating NK cells. Consistent with this, cycling NK cells expressed higher MCL1 (myeloid cell leukemia 1) levels in both control and BCL2-null mice. Finally, we showed that deletion of BIM restored survival in BCL2-deficient but not MCL1-deficient NK cells. Overall, these data demonstrate an essential role for the binding of BCL2 to BIM in the survival of noncycling NK cells. They also favor a model in which MCL1 is the dominant survival protein in proliferating NK cells.
Insights
Natural killer (NK) cells require BCL2 for survival, especially when not actively dividing. Myeloid cell leukemia 1 (MCL1) supports proliferating NK cells, highlighting distinct survival mechanisms.
Area of Science:
- Immunology
- Cell Biology
Background:
- Natural killer (NK) cells are crucial innate lymphoid cells with significant antitumor functions.
- Understanding the molecular mechanisms governing NK cell survival is vital for cancer immunotherapy.
Purpose of the Study:
- To investigate the role of BCL2 (B cell lymphoma 2) in NK cell survival and function.
- To elucidate the interplay between BCL2, MCL1 (myeloid cell leukemia 1), and BIM in regulating NK cell homeostasis.
Main Methods:
- Utilized N-ethyl-N-nitrosourea (ENU)-induced mutagenesis in mice to identify genetic mutations affecting NK cells.
- Performed conditional deletion of Bcl2 in NK cells to assess its specific role.
- Analyzed NK cell counts, apoptosis, and protein expression (MCL1, BIM) under various conditions.
Main Results:
- Identified a hypomorphic mutation in Bcl2 causing NK cell deficiency.
- Demonstrated a nonredundant requirement for BCL2 in the survival of noncycling NK cells.
- Showed that MCL1 is the dominant survival protein in proliferating NK cells, which express higher MCL1 levels.
- Confirmed that BIM deletion rescues survival in BCL2-deficient NK cells, but not MCL1-deficient ones.
Conclusions:
- BCL2 plays an essential, nonredundant role in the survival of noncycling NK cells through its interaction with BIM.
- MCL1 serves as the primary survival protein for proliferating NK cells.
- These findings reveal distinct survival pathways for cycling and noncycling NK cells, offering potential therapeutic targets.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules

